PND10 COST-EFFECTIVENESS STUDY IN PATIENTS WITH MILD TO MODERATELY SEVERE ALZHEIMERS DISEASE- PROJECTED BENEFITS OF DONEPEZIL IN THE UNITED KINGDOM
May 1, 2009, 00:00
10.1016/S1098-3015(10)74017-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)74017-1/fulltext
Title :
PND10 COST-EFFECTIVENESS STUDY IN PATIENTS WITH MILD TO MODERATELY SEVERE ALZHEIMERS DISEASE- PROJECTED BENEFITS OF DONEPEZIL IN THE UNITED KINGDOM
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74017-1&doi=10.1016/S1098-3015(10)74017-1
First page :
Section Title :
Open access? :
No
Section Order :
507